# Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy

> **NCT03526263** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 6 (actual)

## Conditions studied

- Obesity
- Obesity, Morbid
- Obesity; Endocrine
- Bariatric Surgery Candidate

## Interventions

- **PROCEDURE:** Gastric mucosal devitalization

## Key facts

- **NCT ID:** NCT03526263
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-07
- **Primary completion:** 2018-11-29
- **Final completion:** 2018-11-29
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526263, "Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03526263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*